Skip to main content

Citigroup Inc

SEC CIK
0000831001
Latest filing
Aug 3, 2026

TERN holding history

Terns Pharmaceuticals, Inc. in every 13F filed by Citigroup Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TERN overviewAll 13F holders of TERNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of TERN by Citigroup Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−51,551−100.0%Sold outHolders
Q1 202651,551$2.72M<0.1%−17,917−25.8%ReducedHolders
Q4 202569,468$2.81M<0.1%+56,856+450.8%AddedHolders
Q3 202512,612$94.7K<0.1%−25,662−67.0%ReducedHolders
Q2 202538,274$142.8K<0.1%−15,908−29.4%ReducedHolders
Q1 202554,182$149.5K<0.1%−4,998−8.4%ReducedHolders
Q4 202459,180$327.9K<0.1%+9,525+19.2%AddedHolders
Q3 202449,655$414.1K<0.1%−311,425−86.2%ReducedHolders
Q2 2024361,080$2.46M<0.1%+203,519+129.2%AddedHolders
Q1 2024157,561$1.03M<0.1%+150,467+2,121.0%AddedHolders
Q4 20237,094$46.0K<0.1%+6,257+747.6%AddedHolders
Q3 2023837$4.21K<0.1%−13,672−94.2%ReducedHolders
Q2 202314,509$127.0K<0.1%−30,884−68.0%ReducedHolders
Q1 202345,393$537.5K<0.1%−655−1.4%ReducedHolders
Q4 202246,048$468.8K<0.1%+45,347+6,468.9%AddedHolders
Q3 2022701$4.00K<0.1%+182+35.1%AddedHolders
Q2 2022519$1.00K<0.1%−548−51.4%ReducedHolders
Q1 20221,067$3.00K<0.1%−3,219−75.1%ReducedHolders
Q4 20214,286$30.0K<0.1%+2,694+169.2%AddedHolders
Q3 20211,592$17.0K<0.1%+1,177+283.6%AddedHolders
Q2 2021415$5.00K<0.1%−163−28.2%ReducedHolders
Q1 2021578$13.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.